EUVIMEDEUVIMED entdecken
Crossref

R2-DDI: relation-aware feature refinement for drug–drug interaction prediction

Jiacheng Lin, Lijun Wu, Jinhua Zhu, Xiaobo Liang, Yingce Xia, Shufang Xie, Tao Qin, Tie-Yan Liu

Briefings in Bioinformatics · 19.01.2023 · 24 (1)

DOI: 10.1093/bib/bbac576 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Briefings in Bioinformatics, online erschienen am 27.12.2022. Verfasst von Jiacheng Lin und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Automation, Tsinghua University, 30 Shuangqing Rd, Haidian District, 100084 Beijing, China. Hauptthemen laut MEDLINE: Drug-Related Side Effects and Adverse Reactions. Die Arbeit wurde bisher 33-mal zitiert (Crossref) und nennt 41 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Precisely predicting the drug–drug interaction (DDI) is an important application and host research topic in drug discovery, especially for avoiding the adverse effect when using drug combination treatment for patients. Nowadays, machine learning and deep learning methods have achieved great success in DDI prediction. However, we notice that most of the works ignore the importance of the relation type when building the DDI prediction models. In this work, we propose a novel R$^2$-DDI framework, which introduces a relation-aware feature refinement module for drug representation learning. The relation feature is integrated into drug representation and refined in the framework. With the refinement features, we also incorporate the consistency training method to regularize the multi-branch predictions for better generalization. Through extensive experiments and studies, we demonstrate our R$^2$-DDI approach can significantly improve the DDI prediction performance over multiple real-world datasets and settings, and our method shows better generalization ability with the help of the feature refinement design.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Drug-Related Side Effects and Adverse ReactionsHumansDrug InteractionsMachine LearningDrug Discovery

Stichwörter der Autor:innen

consistency trainingdrug–drug interactionfeature refinementrelation-aware

Autor:innen und Institutionen

  • Department of Automation, Tsinghua University, 30 Shuangqing Rd, Haidian District, 100084 Beijing, China.
  • Microsoft Research AI4Science, No. 5 Dan Ling Street, Haidian District, 100080 Beijing, China.
  • CAS Key Laboratory of GIPAS, EEIS Department, University of Science and Technology of China, No. 96, JinZhai Road Baohe District, 230026 Hefei, Anhui Province, China.
  • Institute of Artificial Intelligence, Soochow University, No. 178, Yucai Rd, Gusu District, 215006 Soochow, Jaingsu Province, China.

Zitieren

APA

Lin, J., Wu, L., Zhu, J., Liang, X., Xia, Y., Xie, S., Qin, T., & Liu, T. Y. (2023). R2-DDI: relation-aware feature refinement for drug–drug interaction prediction. Briefings in Bioinformatics, 24(1). https://doi.org/10.1093/bib/bbac576

Vancouver

Lin J, Wu L, Zhu J, Liang X, Xia Y, Xie S, et al. R2-DDI: relation-aware feature refinement for drug–drug interaction prediction. Briefings in Bioinformatics. 2023;24(1). doi:10.1093/bib/bbac576

BibTeX
@article{Lin2023,
  author = {Lin, Jiacheng and Wu, Lijun and Zhu, Jinhua and Liang, Xiaobo and Xia, Yingce and Xie, Shufang and Qin, Tao and Liu, Tie-Yan},
  title = {R2-DDI: relation-aware feature refinement for drug–drug interaction prediction},
  journal = {Briefings in Bioinformatics},
  year = {2023},
  volume = {24},
  number = {1},
  doi = {10.1093/bib/bbac576}
}
Kostenlos starten →